Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Crain's Chicago Business

FDA approves rapid PCR tests from Northwestern biotech spinout

Minute Molecular Diagnostics, a biotech spinout from Northwestern University that says it’s created rapid PCR COVID-19 tests, has received emergency use authorization for its product from the U.S.
Treasure Coast Newspapers

COVID testing FAQs: Your guide to home, over-the-counter antigen and molecular test kits

Assuming you can get your hands on a COVID-19 home test kit — they’ve been in high demand, thanks to the omicron variant — you probably have questions. Am I testing too early or late? Is this brand or ...
GEN

Benefits of PCR-Based Molecular Diagnostics

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
mccormick.northwestern.edu

Monkeypox Rapid PCR Test in Development

Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...
News Medical

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 ...
TMCnet

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent ...

Global Point-of-Care Molecular Diagnostics Market Projected to Reach USD 13.05 Billion by 2035; Growth is Driven by Increasing Need for Fast Near-Patient Testing Globally ...

Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...
Pharmabiz

Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent

Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent: Salt Lake City Friday, March 13, 2026, 15:00 Hrs [IST] Co-Diagnostics, Inc., (Co-Dx), a molecular diagn ...